HNGENYSEHealthcare

Public company intelligence preview

HINGE HEALTH INC

197 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
197
17 filed in the last 30 days
Acquisition / disposition count
57/140
Buy / Sell
Unique insiders active in the last year
11
Current insider positions tracked
46
14 active, 32 exited

Insider compensation

Public aggregate: $17.7M average total compensation across covered insiders.

Governance movement

Public aggregate: 1 governance events in the last year.

Institutional ownership

Public aggregate: 180 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
35
Restricted-sale insiders, 1Y
11
Planned sale shares, 1Y
5.0M
Planned sale value, 1Y
$232.6M
Insiders covered
3
Latest year: 2025
Personnel changes, 1Y
1
Board appointments, 1Y
1
Board departures, 1Y
0

Market context

Basic quote context for the preview.

Price
$54.74
Market cap
$4.3B
Volume
1,252,652
EPS
$0.41
Revenue
$182.3M
Employees
1.4K

Company note

Context before the data.

Company Overview

Hinge Health Inc. is a Healthcare company in the Health Information Services industry that provides technology-enabled virtual musculoskeletal care for joint and muscle pain. Its platform combines software, AI, motion tracking, a proprietary wearable, and an AI-supported clinical care team to deliver personalized treatment for conditions ranging from chronic pain and rehab to women’s pelvic health and fall prevention. The company serves self-insured employers as its core market, with additional exposure to health plans, Medicare Advantage, federal programs, and some international clients.

Its business is built around recurring, subscription-like contracts that are often multi-year and ratably recognized over time, which makes revenue growth more predictable but can delay the timing of reported revenue versus bookings. The 2025 launch of HingeSelect also broadens the offering into in-person provider coordination, extending the company’s end-to-end MSK care model.

Executive Compensation Practices

Executive compensation at Hinge Health is likely shaped heavily by growth, client expansion, retention, and operational leverage, since those are the most important business outcomes in its model. Because the company is scaling a recurring digital health platform, pay structures in this type of healthcare technology business often emphasize equity awards tied to revenue growth, member expansion, margin improvement, and long-term value creation rather than near-term GAAP earnings.

In Hinge Health’s case, IPO-related equity compensation was a major factor in 2025 results, with large stock-based compensation charges tied to vesting conditions triggered by the public listing. That suggests executives and employees may have meaningful equity exposure, and future pay decisions may continue to balance retention with performance-based awards as the company pushes toward stronger non-GAAP profitability and cash generation. For researchers, this means compensation analysis should pay close attention to stock award terms, vesting triggers, and any metrics linked to client growth, retention, and free cash flow.

Insider Trading Considerations

Insider trading patterns at Hinge Health may be influenced by its recent IPO, heavy equity compensation, and recurring revenue model. Following a public listing, insiders often face substantial vesting-related liquidity events, tax-withholding sales, and post-lockup selling pressure, especially when RSUs or PRSUs are converted into tradable shares.

Because the company’s revenue is ratable and management highlights seasonal billings patterns, insiders may be particularly sensitive to timing around quarterly results, contract wins, member growth, and cash flow trends. The healthcare and digital health context also adds regulatory sensitivity, since telehealth, privacy, medical device, and corporate practice compliance issues can materially affect the business and may increase caution around trading windows. Researchers and day traders should watch for insider transactions around IPO-related unlocks, earnings releases, major client expansion announcements, and product/regulatory milestones such as FDA- or international expansion-related updates.

Unlock the full HNGE insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.